Castle Biosciences, Inc. (CSTL)
25.07
+0.02
(+0.08%)
USD |
NASDAQ |
Apr 20, 11:29
Castle Biosciences SG&A Expense (Quarterly) : 56.73M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Delcath Systems, Inc. | 10.53M |
| Assertio Holdings, Inc. | 9.58M |
| CytoSorbents Corp. | 9.612M |
| Odyssey Health, Inc. | 0.1819M |
| Harmony Biosciences Holdings, Inc. | 86.74M |